Skip to main content
SpringerLink
Log in

FDA requires new strategy to ensure safe use of LABAs

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA drug safety communication: new safety requirements for long-acting inhaled asthma medications called Long-Acting Beta-Agonists (LABAs). Internet Document: [3 pages], 18 Feb 2010. Available from: URL: http://www.fda.gov

  2. FDA.FDA Announces New Safety Controls for Long-Acting Beta Agonists, Medications Used to Treat Asthma. Media Release: 18 Feb 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FDA requires new strategy to ensure safe use of LABAs. React. Wkly. 1290, 3 (2010). https://doi.org/10.2165/00128415-201012900-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012900-00006

Keywords

Search

Navigation